536 related articles for article (PubMed ID: 10051493)
21. The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases.
Sagnelli E; Stroffolini T; Mele A; Almasio P; Coppola N; Ferrigno L; Scolastico C; Onofrio M; Imparato M; Filippini P
J Med Virol; 2005 Apr; 75(4):522-7. PubMed ID: 15714480
[TBL] [Abstract][Full Text] [Related]
22. Seroepidemiology of hepatitis A in patients with chronic liver disease.
Saab S; Lee C; Shpaner A; Ibrahim AB
J Viral Hepat; 2005 Jan; 12(1):101-5. PubMed ID: 15655056
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of human cytomegalovirus co-infection in patients with chronic viral hepatitis B and C: a comparison of clinical and histological aspects.
Bayram A; Ozkur A; Erkilic S
J Clin Virol; 2009 Jul; 45(3):212-7. PubMed ID: 19497785
[TBL] [Abstract][Full Text] [Related]
24. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
Chehadeh W; Al-Nakib W
J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
[TBL] [Abstract][Full Text] [Related]
25. Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.
Giannini E; Ceppa P; Botta F; Mastracci L; Romagnoli P; Comino I; Pasini A; Risso D; Lantieri PB; Icardi G; Barreca T; Testa R
Am J Gastroenterol; 2000 Nov; 95(11):3211-7. PubMed ID: 11095344
[TBL] [Abstract][Full Text] [Related]
26. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation.
Farinati F; Cardin R; D'Errico A; De Maria N; Naccarato R; Cecchetto A; Grigioni W
Hepatology; 1996 Jun; 23(6):1468-75. PubMed ID: 8675166
[TBL] [Abstract][Full Text] [Related]
27. [The prevalence of hepatitis G virus in patients with hepatitis B and C virus infections].
Kaya S; Cicioğlu Aridoğan B; Demirci M
Mikrobiyol Bul; 2004 Oct; 38(4):421-7. PubMed ID: 15700668
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C virus antibodies in chronic liver diseases of different aetiology.
Craxi A; Almasio P; Di Marco V; Magrin S; Bruno R; Cammà C; Fiorentino G; Lo Jacono O; Marino L; Palazzo U
Ital J Gastroenterol; 1991 Jun; 23(5):244-8. PubMed ID: 1742513
[TBL] [Abstract][Full Text] [Related]
29. HCV infection is a risk factor for gallstone disease in liver cirrhosis: an Italian epidemiological survey.
Stroffolini T; Sagnelli E; Mele A; Cottone C; Almasio PL;
J Viral Hepat; 2007 Sep; 14(9):618-23. PubMed ID: 17697013
[TBL] [Abstract][Full Text] [Related]
30. Natural course of chronic HCV and HBV infection and role of alcohol in the general population: the Dionysos Study.
Bedogni G; Miglioli L; Masutti F; Ferri S; Castiglione A; Lenzi M; Crocè LS; Granito A; Tiribelli C; Bellentani S
Am J Gastroenterol; 2008 Sep; 103(9):2248-53. PubMed ID: 18637095
[TBL] [Abstract][Full Text] [Related]
31. [GBV-C/HGV, a new virus as one possible cause of hepatitis of unknown etiology].
König J; Summerová M; Kaslíková J; Svejda J; Strakrle V; Gregora E; Nĕmecek V; Procházka B; Rozprimová L; Rocková R
Epidemiol Mikrobiol Imunol; 2001 Aug; 50(3):103-10. PubMed ID: 11550417
[TBL] [Abstract][Full Text] [Related]
32. Little evidence that hepatitis C virus leads to a higher risk of mortality in the absence of cirrhosis and excess alcohol intake: the Swiss Hepatitis C Cohort Study.
Prasad L; Spicher VM; Negro F; Rickenbach M; Zwahlen M;
J Viral Hepat; 2009 Sep; 16(9):644-9. PubMed ID: 19243494
[TBL] [Abstract][Full Text] [Related]
33. Endemic hepatitis B virus infection and chronic liver disease mortality in the Republic of Palau, 1990-2002.
Vogt TM; Goldstein ST; Kuartei S
Trans R Soc Trop Med Hyg; 2006 Dec; 100(12):1130-4. PubMed ID: 16765396
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis viruses and chronic liver disease.
Tangkijvanich P; Theamboonlers A; Hirsch P; Thongngam D; Kullavanijaya P; Poovorawan Y
Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):489-95. PubMed ID: 10774657
[TBL] [Abstract][Full Text] [Related]
35. Viral hepatitis in India.
Acharya SK; Madan K; Dattagupta S; Panda SK
Natl Med J India; 2006; 19(4):203-17. PubMed ID: 17100109
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis and HIV infection during haemodialysis.
Saha D; Agarwal SK
J Indian Med Assoc; 2001 Apr; 99(4):194-9, 203, 213. PubMed ID: 11666025
[TBL] [Abstract][Full Text] [Related]
37. The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance.
Bell BP; Manos MM; Zaman A; Terrault N; Thomas A; Navarro VJ; Dhotre KB; Murphy RC; Van Ness GR; Stabach N; Robert ME; Bower WA; Bialek SR; Sofair AN
Am J Gastroenterol; 2008 Nov; 103(11):2727-36; quiz 2737. PubMed ID: 18684170
[TBL] [Abstract][Full Text] [Related]
38. Clinical and virological improvement of hepatitis B virus-related or hepatitis C virus-related chronic hepatitis with concomitant hepatitis A virus infection.
Sagnelli E; Coppola N; Pisaturo M; Pisapia R; Onofrio M; Sagnelli C; Catuogno A; Scolastico C; Piccinino F; Filippini P
Clin Infect Dis; 2006 Jun; 42(11):1536-43. PubMed ID: 16652310
[TBL] [Abstract][Full Text] [Related]
39. Impact of chronic hepatitis C and/or D on liver fibrosis severity in patients co-infected with HIV and hepatitis B virus.
Lacombe K; Boyd A; Desvarieux M; Serfaty L; Bonnord P; Gozlan J; Molina JM; Miailhes P; Lascoux-Combe C; Gault E; Girard PM
AIDS; 2007 Nov; 21(18):2546-9. PubMed ID: 18025897
[TBL] [Abstract][Full Text] [Related]
40. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]